Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...

The HealthTree Foundation has announced the launch of the new artificial intelligence (AI)-powered personalised Clinical ...

The CHMP recommends conditional marketing authorization of REGN's linvoseltamab to treat adults with relapsed and refractory multiple myeloma.

Tremfya, Stelara and Darzalex have been recommended for ulcerative colitis, Crohn’s disease and multiple myeloma, ...

In spite of recent advances in the management of multiple myeloma, cure has been elusive, with efforts to improve long-term outcomes thwarted by repeated cycles of relapse and remission. This is ...

A woman from Cavan, who is fighting a rare and untreatable type of bone marrow cancer, has spoken of her burning aim to ...

Zoledronic acid injection is indicated for the treatment of hypercalcemia of malignancy and for the treatment of multiple ...

The Clinical Trial Finder Now Matches Multiple Myeloma Patients to Eligible Clinical Trials Based on Their Medical Records ...

STOBOCLO ® (denosumab-bmwo) and OSENVELT ® (denosumab-bmwo) are approved by FDA for all indications of reference products ...

Jefferies backs Lupin, Zydus, and Biocon amid shifting US pharma market shares. Discover why these stocks are set to shine.

Can a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have ...

A team of University of Adelaide researchers is hoping to create a world-first treatment for nerve damage caused by ...